189 related articles for article (PubMed ID: 17828761)
21. Development of a bibliography on religion, spirituality and addictions.
Geppert C; Bogenschutz MP; Miller WR
Drug Alcohol Rev; 2007 Jul; 26(4):389-95. PubMed ID: 17564874
[TBL] [Abstract][Full Text] [Related]
22. Hong Kong enrolled nurses' perceptions of spirituality and spiritual care.
Wong KF; Lee LY; Lee JK
Int Nurs Rev; 2008 Sep; 55(3):333-40. PubMed ID: 19522951
[TBL] [Abstract][Full Text] [Related]
23. HIV prevention and psychoactive drug use: a research agenda.
Des Jarlais DC; Semaan S
J Epidemiol Community Health; 2009 Mar; 63(3):191-6. PubMed ID: 19218258
[TBL] [Abstract][Full Text] [Related]
24. Non drug use- and drug use-specific spirituality as one-year predictors of drug use among high-risk youth.
Sussman S; Skara S; Rodriguez Y; Pokhrel P
Subst Use Misuse; 2006; 41(13):1801-16. PubMed ID: 17118817
[TBL] [Abstract][Full Text] [Related]
25. Integrating clients' religion and spirituality within psychotherapy: A comprehensive meta-analysis.
Captari LE; Hook JN; Hoyt W; Davis DE; McElroy-Heltzel SE; Worthington EL
J Clin Psychol; 2018 Nov; 74(11):1938-1951. PubMed ID: 30221353
[TBL] [Abstract][Full Text] [Related]
26. Spiritual transcendence as a predictor of psychosocial outcome from an outpatient substance abuse program.
Piedmont RL
Psychol Addict Behav; 2004 Sep; 18(3):213-22. PubMed ID: 15482076
[TBL] [Abstract][Full Text] [Related]
27. Religion and spirituality.
Worthington EL; Hook JN; Davis DE; McDaniel MA
J Clin Psychol; 2011 Feb; 67(2):204-14. PubMed ID: 21108313
[TBL] [Abstract][Full Text] [Related]
28. Dispositional predictors of placebo responding: a motivational interpretation of flower essence and gratitude therapy.
Hyland ME; Whalley B; Geraghty AW
J Psychosom Res; 2007 Mar; 62(3):331-40. PubMed ID: 17324684
[TBL] [Abstract][Full Text] [Related]
29. Blessings: the influence of a spirituality-based intervention on psychospiritual outcomes in a cardiac population.
Delaney C; Barrere C
Holist Nurs Pract; 2008; 22(4):210-9. PubMed ID: 18607234
[TBL] [Abstract][Full Text] [Related]
30. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
[TBL] [Abstract][Full Text] [Related]
31. Outcomes using two tailored behavioral treatments for substance abuse in urban gay and bisexual men.
Shoptaw S; Reback CJ; Larkins S; Wang PC; Rotheram-Fuller E; Dang J; Yang X
J Subst Abuse Treat; 2008 Oct; 35(3):285-93. PubMed ID: 18329226
[TBL] [Abstract][Full Text] [Related]
32. [Therapy for patients with substance abuse from point of view of brain science and spirituality].
Kuniwaki H
Seishin Shinkeigaku Zasshi; 2001; 103(12):1055-60. PubMed ID: 11925844
[No Abstract] [Full Text] [Related]
33. The provision of spiritual care by registered nurses on a maternal-infant unit.
Dunn LL; Handley MC; Dunkin JW
J Holist Nurs; 2009 Mar; 27(1):19-28; quiz 31-3. PubMed ID: 19176900
[TBL] [Abstract][Full Text] [Related]
34. Self identity through Ho'oponopono as adjunctive therapy for hypertension management.
Kretzer K; Davis J; Easa D; Johnson J; Harrigan R
Ethn Dis; 2007; 17(4):624-8. PubMed ID: 18072370
[TBL] [Abstract][Full Text] [Related]
35. Barriers to engagement in sleep restriction and stimulus control in chronic insomnia.
Vincent N; Lewycky S; Finnegan H
J Consult Clin Psychol; 2008 Oct; 76(5):820-8. PubMed ID: 18837599
[TBL] [Abstract][Full Text] [Related]
36. Behavioral mediation of the relationship between psychosocial factors and HIV disease progression.
Gore-Felton C; Koopman C
Psychosom Med; 2008 Jun; 70(5):569-74. PubMed ID: 18519885
[TBL] [Abstract][Full Text] [Related]
37. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
38. Behavioral drug and HIV risk reduction counseling (BDRC) with abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial.
Chawarski MC; Mazlan M; Schottenfeld RS
Drug Alcohol Depend; 2008 Apr; 94(1-3):281-4. PubMed ID: 18164145
[TBL] [Abstract][Full Text] [Related]
39. [Psychological impact of HIV tests on drug addicts].
Haas H; Kurz T
Schweiz Rundsch Med Prax; 1988 May; 77(21):582-6. PubMed ID: 3387750
[No Abstract] [Full Text] [Related]
40. Spiritual well-being and practices among women with gynecologic cancer.
López AJ; McCaffrey R; Quinn Griffin MT; Fitzpatrick JJ
Oncol Nurs Forum; 2009 May; 36(3):300-5. PubMed ID: 19403451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
